BOSTON–(BUSINESS WIRE)–Berkshire Partners is delighted to announce that Managing Director Chris Hadley has been named a Top Healthcare Investor of 2025 by GrowthCap. This recognition highlights Mr. Hadley’s deep expertise in healthcare investing and his consistent delivery of strategic and operational insights to Berkshire’s portfolio companies.
Mr. Hadley has served as a pivotal member of Berkshire’s team for over 26 years, earning a reputation as a respected and skilled professional. His ability to build strong relationships with portfolio company leadership is exemplified by his current board roles with Ensemble Health Partners, IVC Evidensia, Precision Medicine Group, U.S. Anesthesia Partners, and Vital Care Infusion Services. Previously, he was significantly involved with PurFoods and United BioSource.
“At Berkshire Partners, we are deeply committed to fostering strong and enduring relationships with founders, CEOs, and management teams throughout our partnerships,” noted Mr. Hadley. “I have been fortunate to be a small part of a tremendous team and this recognition by GrowthCap is a direct reflection of the ‘relationships matter’ and ‘team of teams’ culture approach pursued by all at Berkshire.”
Internally, Mr. Hadley serves as Chair of the Investment Committee and is a member of the Governance and Policy Committee. Beyond his corporate responsibilities, he is deeply committed to philanthropy, serving as Chairman of the Investment Committee for Dana-Farber Cancer Institute where he has served as a trustee for over a decade, among others.
About GrowthCap
Founded in 2013, GrowthCap has provided private company CEOs with insight, exposure, and access to the private capital markets. GrowthCap’s content is distributed to over 25,000 CEOs, senior executives, private equity investors, family offices and institutional limited partners. GrowthCap publishes and distributes content through its website, email newsletter, podcast, and social media.
About Berkshire Partners
Berkshire Partners is a 100% employee-owned, multi-sector specialist investor in private and public equity. The firm’s private equity team invests in well-positioned, growing companies across business & consumer services, healthcare, industrials, and technology & communications. Berkshire is currently investing from its Fund XI, which held its final closing in 2024 with approximately $7.8 billion in commitments. Since inception, Berkshire Partners has made more than 150 private equity investments and has a strong history of collaborating with management teams to grow the companies in which it invests. The firm’s public equity group, Stockbridge, founded in 2007, manages a concentrated portfolio seeking attractive long-term investments. For additional information, visit www.berkshirepartners.com.
Contacts
Greg Winter
Berkshire Partners
[email protected]
